HR/MS-based lipidome analysis of rat brain modulated by Tolcapone
Autores da FMUP
Participantes de fora da FMUP
- Rebouta, J
- D?ria, L
- Fonseca, MM
- Castilla Fern?ndez, G
- Pires, NM
- Loureiro, AI
Unidades de investigação
Abstract
Lipids play key roles in the body, influencing cellular regulation, function, and signalling. Tolcapone, a potent catechol-O-methyltransferase (COMT) inhibitor described to enhance cognitive performance in healthy subjects, was previously shown to impact fatty acid beta-oxidation and oxidative phosphorylation. However, its impact on the brain lipidome remains unexplored. Hence, this study aimed to assess how tolcapone affects the lipidome of the rat pre-frontal cortex (PFC), a region of the brain highly relevant to tolcapone therapeutic effect, while evaluating its influence on operant behaviour. Tolcapone at 20 mg/kg was chronically administered to Wistar rats during a behavioural task and an untargeted liquid chromatography high-resolution mass spectrometry (LC-HR/ MS) approach was employed to profile lipid species. The untargeted analysis identified 7227 features, of which only 33% underwent statistical analysis following data pre-processing. The results revealed an improved cognitive performance and a lipidome remodelling promoted by tolcapone. The lipidomic analysis showed 32 differentially expressed lipid species in tolcapone-treated animals (FC >= 1.2, p-value <= 0.1), and among these several triacylglycerols, cardiolipins and N-acylethanolamine (NAE 16:2) were found upregulated whereas fatty acids, hexosylceramides, and several phospholipids including phosphatidylcholines and phosphatidylethanolamines were downregulated. These preliminary findings shed light on tolcapone impact on lipid pathways within the brain. Although tolcapone improved cognitive performance and literature suggests the significance of lipids in cognition, this study did not conclusively establish that lipids directly drove or contributed to this outcome. Nevertheless, it underscores the importance of lipid modulation and encourages further exploration of tolcaponeassociated mechanisms in the central nervous system (CNS).
Dados da publicação
- ISSN/ISSNe:
- 0731-7085, 1873-264X
- Tipo:
- Article
- Páginas:
- -
- Link para outro recurso:
- www.scopus.com
Journal of Pharmaceutical and Biomedical Analysis Elsevier
Documentos
- Não há documentos
Filiações
Filiações não disponíveis
Keywords
- Lipidome; Tolcapone; Cognition; High -resolution mass spectrometry; Phospholipids; Triglycerides
Proyectos asociados
Mind the gap: An insight into the temporal relationship between initiation of cannabis use and onset of psychosis
Investigador Principal: Maria Augusta Vieira Coelho
Estudo Clínico Académico . 2022
Plasma levels of oleoylethanolamide in patients with feeding and eating disorders
Investigador Principal: Maria Augusta Vieira Coelho
Estudo Clínico Académico . 2022
Perceção do risco associado ao uso de drogas em doentes com história prévia de psicose induzida por cannabis
Investigador Principal: Maria Augusta Vieira Coelho
Estudo Clínico Académico . 2022
Ongoing Clinical Trials with Monoclonal Antibodies in Schizophrenia
Investigador Principal: Maria Augusta Vieira Coelho
Estudo Clínico Académico . 2020
Impulsivity and Its Relationship With Lisdexamfetamine Dimesylate Treatment in Binge Eating Disorder
Investigador Principal: Maria Augusta Vieira Coelho
Ensaio Clínico Académico (Eating Disorder) . 2022
Effect of the COVID-19 pandemic in patients with Obsessive-Compulsive Disorder
Investigador Principal: Maria Augusta Vieira Coelho
Estudo Clínico Académico . 2022
The role of opicapone for the treatment of patients with Parkinson´s Disease: clinical evidence
Investigador Principal: Maria Augusta Vieira Coelho
Estudo Clínico Académico . 2023
O Sistema Endocanabinoide na Patofisiologia da Fibrose Dérmica
Investigador Principal: Maria Augusta Vieira Coelho
Estudo Clínico Académico . 2021
Citar a publicação
Rebouta J,D?ria L,Coelho A,Fonseca MM,Castilla G,Pires NM,Coelho M,Loureiro AI. HR/MS-based lipidome analysis of rat brain modulated by Tolcapone. J. Pharm. Biomed. Anal. 2024. 241. 115971. IF:3,400. (2).